Concord Drugs Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Concord Drugs Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
CONCORD

Click to see a quick summary and important updates about this stock!Dismiss

Concord Drugs Ltd.

BSE: 538965

  • Market Capitalisation info

    ₹24 Cr


  • 12 Month Earnings info

    ₹2 Cr

  • Price to Earnings info

    14.78

₹26.95

As on 16-Aug-2022 IST

up-down-arrow-0.55-2.00%

  • Prev Close info

    27.50

  • Day's Openinfo

    28.00

  • Today's Highinfo

    28.00

  • Today's Lowinfo

    25.25

  • Today's Volumeinfo

    8,968

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Concord Drugs
-16.17 11.83 -3.41 -4.09 15.74 -1.81 --
S&P BSE Healthcare
-11.32 2.87 4.13 -10.21 22.92 12.16 12.30
S&P BSE Small Cap
-4.29 9.37 11.37 6.98 30.90 12.84 15.63
As on 16-Aug-2022
2021
2020
2019
2018
2017
2016
Concord Drugs
46.01 53.18 -33.63 -26.50 -34.69 -19.21
S&P BSE Small Cap
62.77 32.11 -6.85 -23.41 59.64 1.77
S&P BSE Healthcare
20.87 61.45 -3.55 -5.89 0.49 -12.88

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis

        No Review & Analysis are available.

        Other Details

        Incorporated

        1995

        Chairman

        S Nagi Reddy

        Managing Director

        S Nagi Reddy

        Headquarters

        Hyderabad, Telangana
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          ₹23.56 Cr

        • Revenue (TTM) info

          ₹59.06 Cr

        • Earnings (TTM) info

          ₹1.59 Cr

        • Cash info

          ₹0.07 Cr

        • Total Debt info

          ₹12.97 Cr

        • Promoters' ownership info

          49.00%

        • Liquidity info

          Moderate

        • 52 Week range info

          ₹19.50 - 37.40

        • Face value info

          ₹10.00

        • Shares outstanding info

          87,43,750

        • 10 Years Aggregate:

          CFO: ₹19.50 Cr

          EBITDA: ₹44.24 Cr

          Net Profit: ₹9.92 Cr

        About The Company

        • Business

          Manufacture of pharmaceuticals, medicinal chemical and botanical products

        • Incorporated

          1995

        • Chairman

          S Nagi Reddy

        • Managing Director

          S Nagi Reddy

        • Listing info

          BSE: 538965

        • Country

          India

        • Headquarters info

          Hyderabad, Telangana

        • Website info

          www.concorddrugs.in